Overall, our study demonstrated that the assessment of variation in circulating Gal-1, -3, -8, and -9 levels in response to SARS-CoV-2 infection could be used as potential diagnostic and prognostic non-invasive biomarkers of COVID-19. Here, LGALS1 is linked to COVID-19.